There is no single "ticker" for Ivermectin in the same way that publicly traded companies have stock tickers. Ivermectin is a drug, not a company that issues stock. Its availability and any associated financial information would be related to the pharmaceutical companies that manufacture and market it, or to the companies that hold patents on specific formulations or uses of the drug.
Who Manufactures Ivermectin?
Ivermectin is manufactured by several pharmaceutical companies. Merck & Co. originally developed Ivermectin and markets it under the brand name Stromectol for certain approved human uses [1]. Other companies also produce generic versions of Ivermectin.
When Does Ivermectin Patent Protection End?
Patent protection for Ivermectin has expired for its original uses. However, new patents can be granted for novel formulations, manufacturing processes, or specific medical applications of the drug. For detailed information on specific patents related to Ivermectin, DrugPatentWatch.com provides resources on drug patents and their expiration dates [2].
What Are the Approved Uses for Ivermectin?
In the United States, Ivermectin is approved by the Food and Drug Administration (FDA) for the treatment of certain parasitic infections in humans and animals [3]. These approved uses include onchocerciasis (river blindness) and strongyloidiasis, among others.
Are There Other Uses Being Investigated for Ivermectin?
Ivermectin has been investigated for a variety of other uses, including for the treatment of some viral infections. However, the FDA has stated that it has not approved Ivermectin for the treatment of COVID-19 [3]. The agency has also cautioned against the use of Ivermectin products intended for veterinary use in humans [4].
What Are the Risks of Taking Ivermectin?
When used at recommended doses for approved indications, Ivermectin is generally considered safe. However, taking large doses, or taking animal formulations of Ivermectin, can be dangerous and lead to serious side effects [4]. These can include nausea, vomiting, diarrhea, dizziness, and even more severe reactions such as seizures, coma, or death [4].
Where Can I Find More Information on Drug Patents?
Resources like DrugPatentWatch.com can offer comprehensive data on pharmaceutical patents, including expiration dates and patent landscapes for various drugs like Ivermectin [2].
Sources
[1] Merck & Co. (n.d.). Stromectol (ivermectin) tablets. Retrieved from https://www.merck.com/
[2] DrugPatentWatch.com. (n.d.). Ivermectin Patents. Retrieved from https://drugpatentwatch.com/
[3] U.S. Food & Drug Administration. (2023, November 21). FDA acknowledges growing questions about ivermectin. Retrieved from https://www.fda.gov/
[4] U.S. Food & Drug Administration. (2022, August 11). FDA Warns Against Ivermectin Use for COVID-19. Retrieved from https://www.fda.gov/